NLRP3 and myeloid sarcoma: The aim of this study was to evaluate genotype-phenotype correlations focusing on neurological manifestations in a monocentric cohort of 151 patients (with and without (w/o) MS) with predominantly low-penetrance mutations in the NLRP3-, MEFV-, or TNFRSF1 gene.